REGISTER BY 12/31 AND SAVE UP TO $300!
Hear key biotech and pharma leaders discuss the most pertinent industry trends, the market outlook, and best practices for executive leadership.

Plus, a previously announced Fireside Chat with Michael M. Morrissey, PhD, President and Chief Executive Officer, Exelixis.
#BIOCEO20 topics include:
Therapeutic Topics
• Advances in Gene Therapy: Facing Challenges and Adapting for the Future
• Expanding the Toolkit for Fighting Solid Tumors
• Exploring Innovation in Cardiovascular Disease Therapeutics
• Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs
• Preparing for NASH and Other New Liver Treatments
Business Topics
• Commercialization Strategies for Communicating Evidence of a Therapy’s Value
• Election Outlook—Explaining Healthcare Policy Proposals’ Impacts on Innovation and Patients
• Industry Approaches for Hiring and Developing an Inclusive Workforce
• Market Outlook—Market Performance and IPO Class of 2020
• Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

Apply to Present: Highlight your company’s accomplishments and discuss upcoming milestones. Approximately 170 companies will be chosen based on a selection process evaluating a company’s pipeline and R&D activities. Submit an application! |